This leads to the conclusion that the transient regulation of MASP in the early stage of ESCC development may be a kind of defence mechanism, which prevents further progression to more malignant phenotypes, ultimately inhibiting tumour progression. This evidence concerns the gene MASP1 and neoplasm.